Tuberous Sclerosis NFZ — 28 facilities in 23 cities

Tuberous sclerosis is a genetic disease causing benign tumor (hamartoma) growth in the brain, kidneys, heart, lungs, and skin. It manifests with epilepsy, developmental disorders, skin lesions, and kidney cysts. NFZ covers genetic and imaging diagnostics, epilepsy treatment, and through drug programs, everolimus therapy to inhibit brain tumor (SEGA) and kidney tumor (AML) growth.